Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02927262
Title A Study of ASP2215 (Gilteritinib), Administered as Maintenance Therapy Following Induction/Consolidation Therapy for Subjects With FMS-like Tyrosine Kinase 3 (FLT3/ITD) Acute Myeloid Leukemia (AML) in First Complete Remission
Recruitment Active, not recruiting
Gender both
Phase Phase III
Variant Requirements Yes
Sponsors Astellas Pharma Global Development, Inc.
Indications

acute myeloid leukemia

Therapies

Gilteritinib

Age Groups: adult | senior
Covered Countries USA | CAN

Facility Status City State Zip Country Details
Site US10017 Gainesville Florida 32610-0278 United States Details
Site US10030 Jacksonville Florida 32204 United States Details
Site US10012 Chicago Illinois 60612 United States Details
Site US10025 Syracuse New York 13210 United States Details
Site US10007 Portland Oregon 97239 United States Details
Site US10029 Greenville South Carolina 26615 United States Details
Site BR55002 Goiania Goias 74605-020 Brazil Details
Site CA15001 Halifax Nova Scotia B3H2Y9 Canada Details
Site CA15003 Toronto Ontario M5G 2M9 Canada Details
Site CZ42001 Ostrava-Poruba 70852 Czechia Details
Site DK45002 Arhus Region Midtjylland DK 8000 Denmark Details
Site FR33004 Brest Finistere 29609 France Details
Site FR33002 Tours cedex 01 Indre-et-Loire 37044 France Details
Site FR33014 Vandoeuvre les Nancy Meurthe-et-Moselle 54511 France Details
Site FR33007 Pierre-Benite Rhone 69310 France Details
Site FR33001 Bayonne 64100 France Details
Site FR33009 Mulhouse 68070 France Details
Site FR33008 Nice Cedex 2 06189 France Details
Site DE49001 Duisburg Nordrhein-Westfalen 47166 Germany Details
Site DE49008 Stuttgart 70376 Germany Details
Site GR30010 Athens Attiki 10676 Greece Details
Site GR30004 Thessaloniki Kentriki Makedonia 57010 Greece Details
Site GR30009 Athens Greece Details
Site GR30007 Larissa Greece Details
Site HU36003 Nyiregyhaza Szabolcs-Szatmar-Bereg H-4400 Hungary Details
Site IL97205 Jerusalem Yerushalayim 91031 Israel Details
Site IT39011 Milano Lombardia 20141 Italy Details
Site IT39004 Castelfranco Veneto (TV) Treviso 31033 Italy Details
Site IT39008 Bergamo 24127 Italy Details
Site IT39005 Parma Italy Details
Site IT39010 Reggio Emilia 42100 Italy Details
Site IT39002 Roma 161 Italy Details
Site JP81018 Nagoya Aichi Japan Details
Site JP81025 Matsuyama Ehime Japan Details
Site JP81002 Yoshida-gun Fukui Japan Details
Site JP81024 Sapporo Hokkaido Japan Details
Site JP81012 Kobe Hyogo Japan Details
Site JP81004 Kanazawa Ishikawa Japan Details
Site JP81009 Yokohama Kanagawa Japan Details
Site JP81014 Sendai Miyagi Japan Details
Site JP81023 Shimotsuke Tochigi Japan Details
Site JP81011 Tachikawa Tokyo Japan Details
Site JP81010 Aomori Japan Details
Site JP81017 Okayama Japan Details
Site KR82005 Suwon-si Gyeonggi-do 16499 Korea, Republic of Details
Site KR82014 Bucheon-Si Gyeonggido 14584 Korea, Republic of Details
Site KR82013 Goyang Gyeonggido 10408 Korea, Republic of Details
Site KR82008 Namdong Incheon Gwang'yeogsiv 405 760 Korea, Republic of Details
Site KR82003 Hwasungun Jeonranamdo 58128 Korea, Republic of Details
Site KR82012 Seoul Seoul Teugbyeolsi 06351 Korea, Republic of Details
Site KR82006 Busan 49241 Korea, Republic of Details
Site KR82009 Seoul 120-752 Korea, Republic of Details
Site PL48001 Olsztyn Warmińsko-mazurskie 10-228 Poland Details
Site PL48002 Bydgoszcz 85-168 Poland Details
Site PL48007 Poznan Poland Details
Site PT35106 Coimbra 3000 Portugal Details
Site PT35101 Porto 4200-072 Portugal Details
Site RO40005 București Romania Details
Site RS38102 Belgrade 11000 Serbia Details
Site ES34009 Vitoria Alava 01009 Spain Details
Site SE46003 Stockholm Stockholms Lan 171 76 Sweden Details
Site SE46002 Lund 221 85 Sweden Details
Site TW88605 Kaohsiung 112 Taiwan Details
Site TW88604 Kaohsiung 83301 Taiwan Details
Site TW88603 Taipei 114 Taiwan Details
Site GB44007 Exeter Devon EX2 5DW United Kingdom Details
Site GB44019 Plymouth Devon PL6 8DH United Kingdom Details
Site GB44006 Cottingham East Riding Of Yorkshire HU165JQ United Kingdom Details
Site GB44018 London London, City Of WC1E 6BT United Kingdom Details
Site GB44002 Birmingham B95SS United Kingdom Details
Site GB44015 Cardiff CF4 4XN United Kingdom Details
Site GB44020 Leeds LS9 7TF United Kingdom Details
Site GB44004 Nottingham NG5 1PB United Kingdom Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field